U.S. asthma sufferers who use asthma inhalers with ozone-depleting chlorofluorocarbons (CFCs) are urged to talk to their doctors now about switching to a an albuterol inhaler that contains hydrofluroalkane (HFA) propellants instead. CFC inhalers will be banned starting in January.
Asthma patients are advised to switch now, because there are differences between CFA and HFA inhalers that will take time to get used to.
Only Armstron Pharmaceuticals still sells an albuterol CFC inhaler, so most patients will have switched to the new HFA type.
Read the full story here: U.S. alerts asthma patients about inhaler switch (from Reuters).
Delivered by FeedBurner
0 comments:
Post a Comment
Thank you for reading Allergy Be Gone! All comments are moderated and will be approved only if they are on-topic and not abusive. Other factors, such as the use of foul language or excessive links, may cause your comment to fail moderation.
If you enjoyed the article you just read you can subscribe here to get updates by RSS or subscribe by e-mail.
Thanks for reading and commenting.